a φ-measure could also be a vector φ φ φ with each element being such an individual phenomenon indicator.
A biomarker that identifies abnormal or normal is a g-measure g that demonstrates a significant difference between the case population and the control population, and a biomarker that indicates subtypes or stages is one g-measure g that demonstrates a significant characteristic underlying samples of each corresponding group, while a biomarker of prognosis provides a good prediction on post-treatment survival. Some is a common biomarker that is useful to all the uses, while some particularly works for merely one or two of them.
Typically, a g-measure g is an SNP in GWAS or an expression value of a gene in expression profile. Moreover, a g-measure can be a vector g that consists of multiple SNPs in a segment of DNA sequence, where the segment corresponds to a gene or a noncoding RNA (lncRNA, circRNA, etc.) in consideration. In addition, g may consist of a number of features obtained from mutation analysis. For analysing expression profile with the tumour versus its paired adjacent tissue, g is a two-dimensional vector that consists of simply the expressions of tumour and of the paired adjacent tissue, see page 36 in Ref. Xu (2015a) and Fig. 7 in Ref. Xu (2016) . Even generally, a vector g may represent a bio-unit in consideration, which covers more than one gene, e.g., expressions of several mRNAs that group in a signature on a heart map or certain features that represent one biological functional module.
Conventionally, whether a g-measure acts as a biomarker was examined on a set of case-control samples. For examples, a gene expression biomarker for prognosis takes a high value to indicate positive to survival. Alternatively, there may also be a biomarker that takes a low value to indicate positive to survival. Traditionally, such a biomarker reflects a difference between samples of the g-measure without particularly taking a specific condition in consideration. Recently, multiple reasons appear to support that it would be better to examine a biomarker under certain conditions or in a particular environment.
First, the meaning of a biomarker identified unconditionally may change considerably in a particular environment. An example is one recent finding of CDX2 as a gene expression biomarker for prognostic in colon cancer (Dalerba et al. 2016) . Without considering any condition, its high expression is preferred because the rate of 5-year disease-free survival with stage II CDX2-negative colon cancers was significantly lower than the rate with stage II CDX2-positive colon cancers. Interestingly, it was found that the rate of 5-year disease-free survival with stage II CDX2-negative tumours who were treated with adjuvant chemotherapy became significantly higher than the rate with ones who were not treated with adjuvant chemotherapy, i.e., a low expression became preferred under the condition when adjuvant chemotherapy was treated.
Second, the role of some biomarker that is unable to be unconditionally identified will become detectable under a specific condition. One example is one recent study on IDH1-mutant glioma malignant progression (Bai et al. 2016) . Considering all 82 sequenced gliomas conditioning on that they all have IDH1 mutations, the role of rare mutations of NOTCH1 and NOTCH2 was identified, occurring within sequences encoding the EGF-like domains, which is consistent with inactivating mutations identified in squamous cell carcinomas.
Third, a comprehensive study demands jointly considering a biomarker that consists of multiple g-measures or even jointly considering multiple biomarkers, for which one effective way is hierarchical formulation. In its simplest case, jointly considering two parts can be made subsequently by first considering one part and then considering the rest part conditioning on the first part. One example is the recent molecular analysis of gastric cancer that identifies four subtypes of gastric cancer by a binary tree with three layers (Cristescu et al. 2015) , where subtypes MSS/TP53+ and MSS/TP53− are identified by an integrated biomarker named TP53 signature conditioning on an integrated biomarker named EMT signature and an integrated biomarker named MSI signature.
In a summary, a geno-phenotype study involves not only g-measures and φ-measures, but also a set e of enviro-measures (shortly e-measures) that specify certain condition or a particular environment underlying the study. In other words, we actually make an enviro-geno-pheno integrative study, which may be shortly denoted by a notation g − → e φ or g − → e φ φ φ, where each e-measure may represent one of treatments, patient characteristics or g-measures jointly in consideration.
In the rest of this paper, we propose a generic approach as summarised in Table 1 . First, the approach identifies one or several convex subsets in the joint domain of g-measures, φ-measures, and e-measures, with each subset representing a state of the bio-subsystem in our investigation. Shortly, such a state is called enviro-geno-pheno state (E-GPS) that acts as E-GPS biomarker, indicating 'health/normal' versus 'risk/abnormal' together with its associated enviro-geno-pheno conditions. Second, the approach makes association analysis from such E-GPS states to not only φ-measures or clinical phenotypes but also e-measures, towards various tasks that include but are not limited to differentiation, prognosis, subtype, and staging.
Even generally, g-measures may not only be limited to genetic measures but could be also other measures that serve as the inner ground of study, called ground measures (still g-measures shortly). In other words, the E-GPS approach is also applicable to those datamining tasks that can be formulated into the format g − → e φ.
Methods
Whether a living system survives healthily or a machine system runs normally is featured by its internal status that could be one of several types. One major type is 'health/ good/normal' or negative '−' , the other type is 'risk/bad/abnormal' or positive '+' . There could be other types too, e.g., sub-health or slightly abnormal. In addition, there may be a type indicating 'unknown/confusing' or shortly '?' .
Specifically, a system status is measured via a set g of internal intrinsic or ground factors and a set e of environmental factors, as well as a set φ φ φ of the external behaviours or phenotypes that the system demonstrates correspondingly. Let G, E, and to indicate the domain of g, e and φ φ φ, respectively, as illustrated in Fig. 1a , a system variate ξ ∈ D gφe = G × E × � � � represents an enviro-geno-pheno triple and is associated with a label, e.g., coloured green for 'normal' and coloured red for 'abnormal' as illustrated in Fig. 1b , that indicates an instance of the system status. Moreover, a subset R s ⊂ D gφe conceptually describes a possible relation among g, e, and φ φ φ. Not all possible subsets are interesting. We are interested in that R s is convex and every element in R s shares a same type of system status. The system behaves the same as long as ξ locates within R s , namely R s represents one Enviro-Geno-Pheno state (E-GPS ) in D gφe , shortly denoted by s. The system behaviour is actually an external manifestation of one or several such states, as and φ are univariate, the case is illustrated by a scattering map, which is degenerated into an m g × m e × m φ table that represents a discrete distribution when g, e, and φ take m g , m e , and m φ discrete values, respectively. c A convex set R s acts as E-GPS biomarker, with the system status indicated by Type(s) and the boundary condition by COND(s) about genotypes, phenotypes, and environments by the boundary of R s . d The possible system statuses are featured by E-GPS states that are learned from given samples, by minimising the criterion given by Eq. (1) or (4). e For a finite size of samples, we prefer a simple parametric model, e.g., by one of the two choices given in Eq. (7). f An E-GPS state corresponds to a convex subset with all its elements dedicated to the same status type, e.g., s 11 is a biomarker of 'green' , which maybe relaxed to require a probabilistic dedication, i.e., samples falling in a convex subset are mostly dedicated to a same status type. Contrastingly, a c-state is featured by that two status type compete samples, e.g., s 01 and s 10 . g Prognosis analysis can be made per d-state, as addressed in Table 1 (3)(a). In addition, subtype analysis is made per state, with the top row indicating 'green' and 'red' samples and other rows indicating subtypes in binary values. The relation between the E-GPS state in consideration and each subtype is examined by their intersection. h We may compare the configuration of states jointly. In addition, the results of phenotype analysis per state can be combined, with help of the weighting probability p(j|s j ) in accordance with the individual performance of each state. We may further make state transient analysis by estimating the transfer probabilities p(s i |s j ) illustrated in Fig. 1h . For each E-GPS state s, not only its associated type Type(s) indicates the system status, for which we subsequently focus on Type(s) from one of values −, +, ? for simplicity, and the study can be rather straightforwardly extended to other sub-health types, but also the boundary of its corresponding convex set R s describes the condition B s = COND(s) = Boundary(R s ) to stay at this state, as illustrated in Fig. 1c .
Requiring that every element in R s shares a same type of system status, an E-GPS state is featured by its dedication to one specific type of system status, and thus is shortly called a dedicating state or shortly d-state, e.g., the green d-state s (11) in Fig. 1f dedicates to a 'normal' system status. To tolerate some error or disturbance, we may relax to require that every element in R s gets a high enough probability to share a same type of system status, that is, we consider the concept of d-state in a probabilistic sense, e.g., the red d-state s 00 in Fig. 1f dedicates to one 'abnormal' system status. In addition to d-states, we may also need to handle subsets confused with different types or unknown types of samples, shortly we also regard such a subset as a confusing state or c-state, e.g., s 10 in Fig. 1f .
Instead of adopting a standard routine that directly uses one or a set of g-measures as a biomarker of phenotypes that we aim at, we suggest to use each d-state as a biomarker, shortly, called E-GPS biomarker. Its difference from considering merely g measures as a biomarker lays in not just jointly considering g, e as a biomarker. Even without e, an E-GPS biomarker R s ⊂ D gφe degenerates to a binary relation or a subset of G × whilst we traditionally consider a special bi-relation called function F :
Actually, widely studied is a linear or logistic function f (·), which is an example of merely considering g measures as a biomarker. In other words, an E-GPS biomarker extends such a function not only to a bi-relation but also further to a triple-relation R s ⊂ D gφe with e also taken in consideration, featured by the corresponding condition C s that summarises the boundary conditions about genotypes and phenotypes as well as environments.
A representation of R s is learned from a given set of samples, for which we may consider a d-state s to be described by the convex hull of samples of the corresponding type, as illustrated in Fig. 1c (1)
(2)
No longer each subset S ∈ S is guaranteed to be convex. Without requiring such a convexity, we further consider each subset by the following ratio of minority where there are a number n S of the samples in S ∈ S, with n + S red samples and n − S green samples, respectively. We may regard S as a d-state when r S goes below a threshold γ s and n S is bigger than a minimum number n 0 . In this case, we expect to minimise r S for every S ∈ S. Possibly, there is a subset S with its r S being impossibly reduced below γ s . Forcibly minimising such a r S will unfavourably increase the competing ratios of other subsets. Thus, we are better to leave this r S away from being minimised. Considering every S ∈ S jointly, we minimise the following criterion where ε(u, v, w) ≥ 0 is a function with That is, a smaller value J prefers a smaller r S or equivalently a d-state. Moreover, d S reflects a degree of separation between the samples inside and outside S. It follows from ∂ε ∂v ≤ 0 that a smaller value J prefers bigger d S . Furthermore, η S reflects a degree of balance on the numbers of samples over subsets in S, e.g., we may consider the following entropy It follows from ∂ε ∂w ≤ 0 that a smaller value J prefers bigger η S or a configuration with a least number of states and also with samples dedicated to the states in a balanced way.
In implementation, there could be different choices for representing H d + and H d − . Typically, a finite size of samples restrains our preference to a simple parametric model. Two simplest choices are given as follows:
For examples, Choice (a) is illustrated by the dashed circles in Fig. 1e , and Choice (b) is illustrated by the greyed planes in Fig. 1e . The former choice is similar to the general case in Fig. 1d , parameterised by a least number of free parameters to be estimated by minimising the criterion given by Eqs. (1) or (4). However, there are two limitations. First, the spherical shape is not suitable for representing a sample population in an elongated configuration featured by some orientation. Second, there may be some subset in Eq. (2) that is not convex and thus loses the robustness of a convex set.
(7) (a) a hyper-sphere parameterized by a location vector m and a radius a, (b) a hyper-plane parameterized by a location vector m and a normal vector a.
Though the first limitation may become broken with hypersphere replaced by hyper-ellipse, not only it largely increases the number of free parameters and thus becomes prone to overfitting but also some subset in Eq. (2) may still not be convex. Favourably, Choice (b) gets a small incremental in free parameters, i.e., simply with the scalar a replaced by a vector a, such that the second limitation is overcome and the first limitation is at least partially overcome. Specifically, D gφe is partitioned into at least two convex subsets and at most four convex subsets by two hyper-planes, and the resulted subsets may also have some orientation. Again, we may estimate the two hyper-planes by minimising the criterion given by Eqs. (1) or (4) . Illustrated in Fig. 1f is a simple example that D gφe is partitioned into four convex subsets S 11 , S 01 , S 10 , and S 00 by two lines. Specifically, the subset S 11 represents a d-state s 11 as good biomarker of 'green' (i.e., normal), though unconditionally using g as a biomarker cannot differentiate the normal versus the abnormal. As a d-state, samples of the state s 11 are all dedicated to 'green' , while the state s 00 is almost a d-state that corresponds to the subset S 00 that consists of mostly red samples. The other two subsets S 01 and S 10 act as the c-states. Relaxing two lines in Fig. 1f to become adjusted freely, an optimal partition may be obtained by minimising the criterion given by Eq. (4).
This approach differs from the conventional linear discriminating analysis not just in that one hyper-plane is replaced by two hyper-planes, but also in that the classification error is replaced by the dedication degree of samples while the c-states are excluded from disturbing the d-states. Then, the samples of each c-state maybe further divided into two to four convex subsets using this approach too, e.g., the subset S 01 in Fig. 1f can be further divided into two d-states still within D gφe . Recursively doing so, we are led to a tree as illustrated in Fig. 2e . As a whole, red samples are represented jointly by a number of d-states, either in a probabilistic combination as illustrated in Fig. 1h or via a union of convex subsets while this union may be no longer convex. Similarly, red samples are represented by a number of d-states too.
To avoid overfitting, in Eq. (4) we impose a lower bound on the number of samples in each d-state. In addition, we may merge samples of adjacent c-states to form a big c-stage before dividing one c-state into subsets on the next level, as illustrated in Fig. 2f . For a small size of samples, we may further reduce the number of free parameters by restraining two hyperplanes in parallel, i.e., reduce one orientation vector a into a scalar a to denote the distance between two parallel hyper-planes. Learning may be simplified into a two-stage implementation as illustrated in Fig. 2c, d . First, the normal direction of parallel hyper-planes is learned either directly by support vector machine (SVM) (Suykens and Vandewalle 1999; Suykens et al. 2002) as shown in Fig. 2c or with help of Fisher discriminative analysis (FDA) as shown in Fig. 2d . Second, samples are projected onto the normal direction and further divided into three subsets by minimising a simplified version of J(S) given by Eq. (4), as shown in Fig. 2a, b .
In Eq. (3), one sample within S will contribute one count to either n + S or n − S regardless of where it locates. We may consider that each sample x ∈ S is associated with weight coefficients w + (x) for red samples and w − (x) for green samples, based on which we modify n There could be two types of choices for getting w + (x) and w − (x). One based on how well x belongs to the corresponding state. A weight tends to be small if x marginally belongs to the state (e.g., locating near the boundary of S) but large if x firmly belongs to the state (e.g., locating deep inside S). The other bases on distributions p(x|+) of red samples and p(x|−) of green samples may be given by nonparamatric kernel estimation as follows:
Fig. 2 Learning E-GPS-and E-GPS-based analysis a Learning E-GPS with J(S)
given by Eq. (4) simplified into J(a 1 , a 2 ), where η S is given by Eq. (6) and ≥ 0 is a weight for the role of η S . b Two lines in special cases with only two free parameters. c We may get three convex subsets by considering two parallel lines featured by three free parameters. One way for learning the two lines is using support vector machine (SVM) (Suykens and Vandewalle 1999; Suykens et al. 2002) for several different choices of the margin a among which we pick the best one according to J. d Alternatively, two parallel lines may also be obtained in two steps. First, we find the normal direction of the two lines by SVM and then project all the samples orthogonally onto the direction. Second, we treat the projected samples in the same way as in (b). Instead of SVM, the normal direction may also be determined by either Fisher discriminative analysis (FDA) or principal component analysis (PCA). e Recursively, we perform the division as illustrated in (c) or (d) on each c-state, ..., so on so forth, until all the remaining c-states are noncuttable, see Fig. 1f . c-state (Confusing state); otherwise, i.e., two status types compete samples in R s , e.g., the states s 10 and s 01 in Fig. 1f (c) c-state (cuttable vs noncuttable) It is a c-state with at least one convex subset that is able to be cut off as a d-state, e.g., the state s 01 in Fig. 1f ; otherwise the c-state is said to be noncuttable under the current settings of D gφe , e.g., the state s 10 in Fig. 1f (d) Learning configuration of states Overall, a set of at least one d-state and c-states (if any) is learned from a given set of samples, featured by not only these states but also their configuration that encodes the locations and mutual relations of these states, as illustrated in Fig. 1h (2) Refinements of E-GPS states (a) cutting Cut a cuttable c-state by linear separation, e.g., SVM (Suykens and Vandewalle 1999; Suykens et al. 2002) or FDA by Eqs. (11) and (12) in Ref. Xu (2015a) , via refining condition, e.g., the red line cuts s 01 in Fig. 2f 
S } significantly by χ 2 test or Fisher exact test to identify whether this state is good for prognosis, while the boundary of this state indicates the conditions under which the judgement is made. Moreover, prognosis of a unlabelled sample may be made by an one-class classifier obtained from these conditions Survival analyses plot K-M curves on samples with survival record and make the log rank test or the Cox proportional hazards test
Subtype analyses stratify samples of this state into each subtype, test the enrichment of each subtype in this state, plot K-M curves on each stratification, and examine the correlation or the intersection of each subtype to good and bad prognosis, as shown in Fig. 1h (b) analysis cross d-states Differentiation test on whether there is a significant difference pair-wisely either between samples of different d-states or between samples associated with different values of a phenotype, in one of the following manners: * A t-test when we ignore e and merely consider a univariate g; * A multivariate test, e.g., Hotelling test Hotelling (1931) , BBT test [see Table 6 in Ref. Xu (2015a) where n + , n − are the total number of red and green samples, respectively, d is the dimension of x, and h > 0 is a small smoothing parameter. One simple example of K (
) is a Gaussian distribution with its mean ξ and the covariance h d I.
As summarised in Table 1 , the E-GPS approach is featured by identifying the system status via the E-GPS states that are learned from a given set of samples as addressed previously in this section and then further refined cutting, merging, growing as addressed in Table 1 (2). Subsequently, we conduct various conditional phenotype analyses based on the E-GPS states, as summarised in Table 1(3) .
Discussions
The E-GPS approach may find many uses in genomic biomarkers and cancer genetics, of which several applications are summarised in Table 2 , including not only expression analyses and transcriptomic analysis of mRNA, lncRNA, and circRNA but also whole genome sequencing-based joint SNV analyses, mutation analyses, and methylation analyses, etc.
Additionally, it is also interesting to notice those degenerated situations with phenotype information unknown, e.g., all the red or green coloured points are turned into black dots. In such cases, all the states are degenerated into a same type, namely a unknown state or shortly called U-state. Each U-state actually represents a cluster of samples without any label information, and the task of identifying states is degenerated into clustering analysis, for which one possible method is learning a mixture of multiple local subspaces, e.g., see Algorithm 5 in Ref. Xu (2015b) . In addition, we may consider (9) Staging that is related to subtypes but different, staging involves subtypes in a temporal order. The later stage is usually more serious than the earlier stage, which may be learned via the transfer probabilities p(s i |s j ) cross the states in Fig. 1h Cross-state integration by comparing the configuration of states to enhance the differentiation study above. Moreover, cross-state combination can further provide better performance, as illustrated in Fig. 1h . Given the output measure ζ j,t (e.g., p value, classification error, and predicted regression) for a particular sample t, we may get one weighted average ζ t = j ζ j,t p(s j |t), as well as a combined classification rule the binary factor analysis that describes 2 m states with the number of free parameters significantly reduced, e.g., see Algorithm 6 and Algorithm 7 in Ref. Xu (2015b) . Without considering phenotype information, the task nature will become really different from the E-GPS approach, in which phenotype analysis takes a core role in various tasks. We may use unsupervised learning as a preprocessing stage and the resulted clusters as one initial state configuration, on which the E-GPS study is further performed to take phenotype information in consideration.
In many biomarker searching tasks, the data may be mixed up by samples with phenotypes available and samples with phenotype unknown or partially missing. Considering unlabelled data may help to improve performances, which relates to semi-supervised Fig. 3 A possible extension: getting E-GPS biomarkers by deep learning. a Considering many genes and multiple conditional measures in a bio-system (e.g., a pathway) that consists of far more than a few genes, we may consider a multiple-layer network by deep learning, such as stacked RBMs (Hinton and Salakhutdinov 2006) and LMSER (Xu 1991 (Xu , 1993 featured by unsupervised learning for a hierarchical abstraction of biomarkers. b According to Turing-Church thesis, the class of partial recursive functions is precisely the functions that can be computed by Turing machines, which provide an interesting perspective for understanding deep learning. The basic functions are involved within each layer, and the operators of composition and primitive recursion correspond a forward processing across different layers (namely what is usually called 'deep'), while the minimisation operator corresponds a recurrent process from upper layers back to lower layers. From this perspective, we speculate that the class of functions performed by deep neural networks is also the class of functions that can be computed by Turing machines, for which 'deep' and 'recurrent' are indispensable learning, e.g., see Algorithm 9 in Ref. Xu (2015b) for semi-supervised clustering and Algorithm 11 in Ref. Xu (2015b) for semi-supervised binary factor analysis.
Another possible extension is getting the E-GPS biomarkers by deep learning multiple-layer networks, especially when we consider many genes and multiple conditional measures in a bio-system (e.g., pathway) that consists of far larger than a few genes. As illustrated in Fig. 3a , examples include stacked restricted Boltzmann machines (RBMs) (Hinton and Salakhutdinov 2006) and Least mean square error reconstruction (LMSER) (Xu 1991 (Xu , 1993 . Interestingly, the class of functions performed by deep neural networks is here speculated to be equivalently the class of functions that can be computed by Turing machines, from the perspective of partial recursive functions.
Conclusion
In the joint domain D gφe of geno-measures, pheno-measures, and enviro-measures, those elements that locate adjacently in a convex subset are identified as forming a state as biomarkers. In place of a conventional biomarker that uses one or multiple g-measures as a biomarker unconditionally, this E-GPS approach provides a new biomarker analysis tool that considers not only geno-variables conditionally on certain focused domain but also the joint enviro-geno-pheno effect, as well as the E-GPS state based phenotype analyses such as differentiation, prognosis, subtype, staging, and pathogenic progression. Specifically, a two-stage method is proposed for learning these E-GPS states, and several possible applications are suggested. Moreover, it is further addressed that such an E-GPS approach facilitates integrative study of expression and sequencing.
